The DOI matches its Crossref record.
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
Abstract
Nephrotoxicity represents a serious side effect of immunosuppression following liver transplantation. In order to compare the nephrotoxic action of CsA and FK506 in a clinical setting, we evaluated the incidence of early and late nephrotoxicity in 121 patients, 60 of whom were randomly assigned to CsA- and 61 to FK506-based immunosuppression. Early postoperative renal insufficiency (between PODs 0 and 30; SCr 1.5-3 mg/dl) was observed to a similar extent in patients treated with CsA (38.3%) and FK506 (42.6%). Early postoperative acute renal failure (ARF) (SCr > 3 mg/dl) was observed in 18.0% of patients in the FK506 treatment group and 18.3% of patients receiving CsA therapy. Approximately half the patients with ARF required hemodialysis (CsA: 11.7%; and FK506: 8.2%). All patients with early postoperative ARF requiring hemodialysis survived for more than one year. New onset of late ARF (between PODs 30 and 365) was observed in 6.6% of patients receiving FK506 therapy and in 1.7% in the CsA treatment group as a result of severe infection with multiple organ failure syndrome (MOFS). There was 100% mortality in patients with late ARF requiring hemodialysis. Etiology and prognosis of early and late ARF seem to be completely different. Early ARF was associated with severe coagulopathy and a rise in bilirubin and free hemoglobin, and was accompanied by impaired liver function. Mean onset of hemodialysis in CsA-treated patients was POD 1 and in FK506-treated patients POD 6, which disclosed a different time course of drug-specific nephrotoxicity of CsA and FK506 in early ARF. In contrast, late ARF occurred in both treatment groups only as a part of the MOFS in association with severe infections, an observation consistent with the assumption of overimmunosuppression rather than a primary nephrotoxic effect. Late renal insufficiency appeared in 23.3% of CsA- and in 29.4% of FK506-treated patients, and represented a slowly progressing form of drug-specific nephrotoxicity of CsA and FK506. These preliminary results demonstrate a similar outcome in terms of both early and late nephrotoxicity, but longer follow-up will delineate the overall efficacy and toxicity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gonwa, T. A., Mai, M. L., Melton, L. B., Hays, S. R., Goldstein, R. M., Levy, M. F., & Klintmalm, G. B. (2001) · Transplantation · doi:10.1097/00007890-200112270-00012 · Cited by 493
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
Bennett, W. M., DeMattos, A., Meyer, M. M., Andoh, T., & Barry, J. M. (1996) · Kidney International · doi:10.1038/ki.1996.415 · Cited by 436
CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION: A Retrospective Analysis
Fisher, N. C., Nightingale, P. G., Gunson, B. K., Lipkin, G. W., & Neuberger, J. M. (1998) · Transplantation · doi:10.1097/00007890-199807150-00010 · Cited by 302
Schlitt, H. J., Barkmann, A., Böker, K. H., Emmanouilidis, N., Rosenau, J., Bahr, M. J., Tusch, G., Manns, M. P., Nashan, B., & Klempnauer, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04055-1 · Cited by 256
Kim, D.-S., Yoon, Y.-I., Kim, B. K., Choudhury, A., Kulkarni, A., Park, J. Y., Kim, J., Sinn, D. H., Joo, D. J., Choi, Y., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10629-3 · Cited by 47
Metadata
- Authors
- Platz, K.-P., Mueller, A. R., Blumhardt, G., Bachmann, S., Bechstein, W.-O., Kahl, A., & Neuhaus, P.
- Venue
- Transplantation
- Published
- 1994-07
- Volume
- 58
- Issue
- 2
- Pages
- 170-178
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W4234566972
- Cited by
- 219
- References
- 0
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION. https://app.cochat.ai/papers/10.1097/00007890-199405820-00007
- The paper
- Platz, K.-P., Mueller, A. R., Blumhardt, G., Bachmann, S., Bechstein, W.-O., Kahl, A., & Neuhaus, P. (1994). NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION. Transplantation. https://doi.org/10.1097/00007890-199405820-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.